Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $90

Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight and lowers the price target from $98 to $90.